The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients. 4492
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009
Correlation between pleural cytology, radiolgy and histology in mesothelioma: a 3 year retrospective study Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003
Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Malignant pleural mesothelioma: CT findings in 49 patients Source: Eur Respir J 2002; 20: Suppl. 38, 271s Year: 2002
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019
Pleurodosis through drain for malignant pleural effusion : a case control study Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
Female pleural mesothelioma in a French population-based case-control study Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009